Agilon Health (AGL) Long-Term Investments (2021 - 2023)

Agilon Health (AGL) has 3 years of Long-Term Investments data on file, last reported at $5.1 million in Q1 2023.

• For the quarter ending Q1 2023, Long-Term Investments fell 28.86% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2023 stood at $5.1 million (down 28.86% YoY), and the FY2022 full-year result was $4.7 million, down 27.01% from the prior year.
• Long-Term Investments for Q1 2023 stood at $5.1 million, up from $4.7 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $7.2 million in Q1 2022 and bottomed at $3.6 million in Q2 2022.
• The 3-year median for Long-Term Investments is $5.8 million (2021), against an average of $5.6 million.
• The widest annual swing landed in 2022, when Long-Term Investments fell 27.01%; it then retreated 28.86% in 2023.
• A 3-year view of Long-Term Investments shows it stood at $6.4 million in 2021, then decreased by 27.01% to $4.7 million in 2022, then advanced by 10.5% to $5.1 million in 2023.
• The last three Long-Term Investments figures came in at $5.1 million (Q1 2023), $4.7 million (Q4 2022), and $6.4 million (Q3 2022), per Business Quant data.

Peer Comparison